CANCER LOCATION
Shi et al. retrospectively reviewed 2015 patients undergoing oesophagectomy from January 1984 to December 1995. Nine hundred and eighty-eight met inclusion criteria, which included (i) thoracic oesophagus squamous cell cancer, (ii) oesophagectomy only, without neoadjuvant or adjuvant therapy, (iii) R0 resection, (iv) 12 or more regional lymph nodes resected, (v) complete records and (vi) 10-year follow-up. Surgical inclusion criteria assured curative resection with adequate lymphadenectomy and thus a study group of well-classified pN patients underwent oesophagectomy alone. The size of Shi et al.'s study group is repeatedly decreased by exclusions and appropriate confinement of cancer location to patients with pT2-T3N0M0 cancers; pT2N0M0 patients comprise 64% of the study group and 31% of oesophagectomy patients.
However, an unusual study interval and need for 10-year followup are peculiar inclusion criteria. These patients had oesophagectomy from 20 to 30 years ago, raising questions about transferability of this experience to the 21st century and 7th edition staging. The need for 10-year follow-up, not possible for most oesophageal cancer patients because of high early cancer-related mortality, is unnecessary because actuarial methods permit follow-up variation, and even short follow-up of more recent operations informs the early portion of the distribution of times until death.
Distribution of cancer location in this series was upper (2%), middle (78%) and lower (20%)-notably fewer cancers at extremes of cancer location and an overwhelming predominance in the middle thoracic oesophagus, a different distribution from that used to develop 7th edition staging. Distribution of grade was G1 (39%), G2 (49%) and G3 (12%), dissimilar from more evenly distributed 7th edition data of G1 (46%), G2 (33%) and G3 (21%). Importantly, interplay of cancer location and histological grade may result in further magnification of these dissimilarities and thus limit comparisons.
Analytic techniques used to assess survival differences consisted of multiple stratifications of the data and applications of log-rank testing. Significant classifications were next identified through repeated Cox proportional hazard analyses. Repetitive use of these techniques was employed in an attempt to confirm previously identified pTNM subsets and nonanatomical classifications with significant survival differences. This piecemeal strategy is suboptimal for exploring complex interactions among classifications because investigation of one variable is not adjusted for any other. Multiple applications of tests also increase the probability of identifying chance associations. It is a doubtful patchwork strategy for constructing optimal stage groupings, as accomplished using the random forest machine learning technique [5] .
Analysis for the entire group did not identify cancer location as important in staging, but cancer location was significant in pT2-T3N0M0 patients. Although the analysis detected survival differences among all three cancer locations, it was incapable of exploring monotonicity, distinctness and homogeneity of stage groupings (as can be achieved using random forest analyses) and thus was unable to recognize the importance of combining upper and middle thoracic cancer locations for optimal staging of pT2-T3N0M0 squamous cell cancers. Although repeated analysis confirmed differences among the three stage subgroupings, this analysis was unable to confirm optimal combinations of cancer location and histological grade to produce best stage groupings. Significant differences exist between Shi et al.'s data and analyses used to construct the 7th edition, leading to questions about comparability.
GEOGRAPHIC LOCATION
There have been small single-institution Asian reviews of 7th edition staging of squamous cell cancer that failed to identify the importance of cancer location [6] [7] [8] . These studies share data and analysis problems [9] . The authors choose to explain these shortcomings by presumed special differences in Asians with oesophageal cancer. Shi et al. perpetuate the misconception that 'Eastern patients are known to differ biologically from esophageal cancer patients in Western countries'; however, this statement is supported only by one-sided views of the experience. Random forest analysis of the only available worldwide data did not detect a difference between East and West in survival and staging after oesophagectomy for squamous cell cancers [2, 3] .
TEMPORAL LOCATION
There is ongoing debate concerning components of staging. The Union for International Cancer Control's (UICC) historical position has been promotion of anatomical stage groupings based on TNM classifications alone. The AJCC 7th edition charge resulted in adding non-anatomical classifications in determination of stage groupings. This disharmony led to confusion, frustration and dissatisfaction with the AJCC 7th edition. Thus, AJCC is refocusing the goals of the 8th edition. Stage groupings will be TNM-based. Additional prognostic factors will be added as necessary. This importantly relegates stage groupings to coarse treatment stratifications for patient cohorts, leaving individual patient treatment decisions and prognostication to be based on anatomical TNM factors and important patient, non-anatomical cancer and treatment factors [9] . Delay in performing this analysis and its publication more than 5 years after introduction of the 7th edition staging recommendations may render Shi et al.'s literature contribution of historical interest only. Timing of this publication is crucial to its value in the staging debate.
LOCATION, LOCATION, LOCATION: THE 7TH EDITION AND BEYOND
The 7th edition oesophageal cancer staging was the first attempt at data-driven oesophageal cancer staging for the AJCC and UICC Cancer Staging Manuals. It used worldwide data from multiple locations. Histopathological cell type, histological grade and cancer location augmented TNM classification in stage groupings. However, sophisticated analysis demonstrated cancer location had a very limited role only for pT2-T3N0M0 squamous cell cancers, which was also importantly modified by dichotomized histological grade.
Continued challenges of oesophageal cancer staging by the analysis of single-institution experiences are expected as the 8th edition further refines oesophageal cancer staging, using expanded worldwide data and refined random forest analysis to meet present day staging goals. It is unfortunate that these efforts will be directed at testing evolving staging recommendations rather than assisting in their fundamental construction.
Although a consideration in oesophageal cancer, 'location, location, location' is far from the most important factor. 
